Teladoc Health (TDOC) Shares Outstanding (Weighted Average) (2016 - 2025)
Teladoc Health (TDOC) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $176.2 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 3.32% to $176.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176.2 million through Dec 2025, up 3.32% year-over-year, with the annual reading at $176.2 million for FY2025, 3.32% up from the prior year.
- Shares Outstanding (Weighted Average) hit $176.2 million in Q4 2025 for Teladoc Health, roughly flat from $176.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $176.9 million in Q3 2025 to a low of $152.2 million in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $165.9 million across 5 years, with a median of $164.6 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): surged 107.66% in 2021 and later increased 1.12% in 2022.
- Year by year, Shares Outstanding (Weighted Average) stood at $156.9 million in 2021, then rose by 2.88% to $161.5 million in 2022, then increased by 1.93% to $164.6 million in 2023, then increased by 3.64% to $170.6 million in 2024, then increased by 3.32% to $176.2 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for TDOC at $176.2 million in Q4 2025, $176.9 million in Q3 2025, and $175.9 million in Q2 2025.